High Resolution Melting Analysis Market - Databook 2025 to 2034

The global high resolution melting analysis market size was calculated at USD 322 million in 2024 and is predicted to attain around USD 424.41 million by 2034, expanding at a CAGR of 2.8% from 2025 to 2034.

High Resolution Melting Analysis Market Report Highlights

• North America high resolution melting analysis market dominated the global market and accounted for the highest revenue share in 2024.
• Asia Pacific region is anticipated to fastest-growing during the forecast period.
• By product, the instrument segment dominated the high resolution melting analysis market in 2024 and accounted for the highest revenue share.
• By product, the software segment is expected to grow fastest during the forecast period.
• By application, the detection of acquired mutations/mutation scanning/SNP typing segment held the highest revenue share in 2024 for the high resolution melting analysis market.
• By application, the epigenetics/methylation profiling and drug-resistance segment is anticipated to grow fastest during the forecast period.
• By end-use, the academic research segment accounted for the largest revenue share in 2024 for the high resolution melting analysis market.
• By end-use, the clinical diagnostics segment is expected to grow fastest during the forecast period.

Industry Valuation and Growth Rate Projection

The high resolution melting analysis market refers to the production, distribution, and application of high resolution melting analysis (HRM analysis), which is the quantitative analysis of the melt curves of product DNA fragments following PCR amplification. High resolution melting can be considered the next-generation application of amplicon melting analysis. High resolution melting analysis generates DNA melt curve profiles, which are both specific and sensitive enough to distinguish nucleic acid variation in an exploratory setting and routine detection of known variants. High resolution melting analysis is a powerful technique in molecular biology for the detection of mutations, polymorphisms, and epigenetic differences in double-stranded DNA samples.

High resolution melting analysis is a relatively new, post-PCR analysis method used to identify variations in nucleic acid sequences. This method is based on detecting small differences in PCR melting curves. The benefits of high resolution melting analysis include it is fast and powerful, due to which it can accurately genotype a huge number of samples in a short time, with a high level of accuracy and high reproducibility and capability of analyzing many CpG within a region. Benefits of high resolution benefits include more pixels allowing for finer details, smoother gradients, and crisper edges, resulting in a more realistic and visually pleasant representation.

High resolution melting analysis plays an important role in pharmaceutical research, specifically in identifying genetic markers for disease and drug response, which drives the growth of the high resolution melting analysis market. High resolution melting curve analysis has high specificity and sensitivity for the detection of rifampin resistance in Clinical M. tuberculosis isolates. This method may be a good alternative to conventional drug susceptibility tests in clinical practice.

This method is fast and powerful. Therefore, it can quickly and accurately determine the genotype of many samples, and it can also be easily used by any unskillful laboratory staff with access to a real-time PCR device. High resolution melting analysis can also be used to scan for mutations in target genes for the identification of variant samples prior to sequencing analysis. Pharmaceutical research plays an important role in discovering new or enhanced methods to improve therapeutic approaches and address unmet medical needs.

Rising personalized medicine demand is driving the growth of the high resolution melting analysis market. There are many benefits to personalized medicines, ranging from enhancing diagnostic accuracy to identifying the best treatment option for a patient based on their characteristics, to targeted therapy that increases the likelihood of successful treatments, reduces side effects, allows for better prevention, and most importantly reduces healthcare costs, increases patient engagement, and also promotes research and innovation. Personalized medicine is emerging to treat the underlying causes of disease and promote overall health. Technological and interdisciplinary advances are essential for the collection and analysis of health data, promoting personalized and accurate treatments. Personalized medicine is already being used in clinical care, and it is used only as the standard procedure in a small number of settings.

Advancements in genomic research are driving the growth of the high resolution melting analysis market. High resolution DNA melting analysis using the LightScanner is a sensitive method for variant detection in genomic and whole genome amplified DNA. The whole genome amplified DNA appears to have a slightly higher failure rate and lower specificity than genomic DNA. High resolution melting analysis is a sensitive and specific method for molecular diagnosis of genetic disorders. It does not need labeled probes, processing, or separations after PCR. It is efficient and can be used for mutation pre-screening in many genetic disorders.

• According to a report published in November 2024 by TredEconomy, in 2023, the world exports of pharmaceutical products exceeded $805 billion (according to the external trade statistics of 131 countries).